Review of studies with urapidil in elderly hypertensives.

Review of studies with urapidil in elderly hypertensives. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Review of studies with urapidil in elderly hypertensives. Abstract Text:

Urapidil, an antihypertensive agent with dual action (alpha 1-adrenergic antagonist and 5HT1A agonist) is well established in the treatment of arterial hypertension. The present brief review deals specifically with data obtained with urapidil in the treatment of elderly hypertensive patients. Some of these data, dealing with 245 patients aged > or = 65 years, have previously been published, but additional data from more than 5000 hypertensive patients in this age group on file will be reviewed as well. This unique and large data base clearly indicates that urapidil is an effective antihypertensive agent also when used in the treatment of elderly patients. Moreover, urapidil is well tolerated in this age group and has, in addition, a potentially favourable lipid profile. It may therefore be concluded that urapidil is well suited for the treatment of hypertension in the elderly.

Review of studies with urapidil in elderly hypertensives. Publishing Authors By Initials

For similar heterocyclic compounds: heterocyclic compounds, 1-ring: piperazines research abstracts see: heterocyclic compounds: heterocyclic compounds, 1-ring: piperazines research

PUBMED ID PMID:

MEDLINE DATE:

Review of studies with urapidil in elderly hypertensives. Journal Published:

PUBLICATION TYPE: Review

Journal: Blood pressure. Supplement

VOLUME: 3

Page Numbers: 21-5

Journal Abbreviation:

ISSN: 0803-8023

DAY: 26

MONTH: 02

YEAR: 1995

Review of studies with urapidil in elderly hypertensives. Information

Number of References: 21

LANGUAGE: eng

NlmUniqueID: 9300787

Review of studies with urapidil in elderly hypertensives. Keywords Mesh Terms:

KEYWORDS: Piperazines

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Review of studies with urapidil in elderly hypertensives. Information

Substance Name: urapidil

Registry Number: 34661-75-1

Grant and Affiliation Information for Review of studies with urapidil in elderly hypertensives.

AFFILIATION: Department of Geriatrics, Clinical Hypertension Research, University of Uppsala, Sweden.

Country: NORWAY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Blood Press Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Review of studies with urapidil in elderly hypertensives Related Publications

• Assessing the chemical and biological diversity of an ion channels knowledge database.
• Review of studies with urapidil in elderly hypertensives.